Skip to main content

Part of the book series: Updates in Surgery ((UPDATESSURG))

  • 793 Accesses

Abstract

This chapter provides an overview of imaging modalities currently employed in assessing colorectal cancer (CRC) recurrence in the pelvis. Special emphasis is given to the role of magnetic resonance imaging (MRI) and its significance in planning an effective therapeutic strategy in the individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abulafi AM, Williams NS (1994) Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg 81:7–19

    Article  CAS  PubMed  Google Scholar 

  2. Titu LV, Nicholson AA, Hartley JE et al (2006) Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer. Ann Surg 243:348–352

    Article  PubMed  PubMed Central  Google Scholar 

  3. Goldberg RM, Fleming TR, Tangen CM et al (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27–35

    Article  CAS  PubMed  Google Scholar 

  4. Huguier M, Houry S, Barrier A (2001) Local recurrence of cancer of the rectum. Am J Surg 182:437–439

    Article  CAS  PubMed  Google Scholar 

  5. Schmidt GP, Baur-Melnyk A, Haug A et al (2009) Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer. Eur Radiol 19:1366–1378

    Article  CAS  PubMed  Google Scholar 

  6. Dresen RC, Kusters M, Daniels-Gooszen AW et al (2010) Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 256:143–150

    Article  PubMed  Google Scholar 

  7. Guillem JG, Díaz-González JA, Minsky BD et al (2008) cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol 26:368–373

    Article  PubMed  Google Scholar 

  8. Desch CE, Benson AB, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23:8512–8519

    Article  PubMed  Google Scholar 

  9. ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 16:16–17

    Article  Google Scholar 

  10. ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of advanced colorectal cancer. Ann Oncol 16:18–19

    Article  Google Scholar 

  11. ESMO Guidelines Task Force (2005) ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of rectal cancer. Ann Oncol 16:20–21

    Article  Google Scholar 

  12. Selzner M, Hany TF, Wildbrett P et al (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240:1027-1034

    Article  PubMed  PubMed Central  Google Scholar 

  13. Stueckle CA, Haegele KF, Jendreck M et al (2005) Improvements in detection of rectal cancer recurrence by multiplanar reconstruction. Radiologe 45:930–935

    Article  Google Scholar 

  14. Blomqvist L, Holm T, Goranson H et al (1996) MR imaging, CT and CEA scintigraphy in diagnosis of local recurrence of rectal cancer. Acta Radiol 37:779–784

    Article  CAS  PubMed  Google Scholar 

  15. Pema PJ, Bennett WF, Bova JG et al (1994) CT vs MRI in diagnosis of recurrent recto sigmoid carcinoma. J Comput Assist Tomogr 18:256–261

    Article  CAS  PubMed  Google Scholar 

  16. Mäkelä JT, Laitinen SO, Kairaluoma MI (1995) Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 130:1062–1067

    Article  PubMed  Google Scholar 

  17. Bleeker WA, Mulder NH, Hermans J et al (2001) Value and cost of follow-up after adjuvant treatment of patients with Dukes’ C colonic cancer. Br J Surg 88:101–106

    Article  CAS  PubMed  Google Scholar 

  18. Primrose JN, Perera R, Gray A et al (2014) FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 311:263–270

    Article  CAS  PubMed  Google Scholar 

  19. Nakamoto Y, Sakamoto S, Okada T et al (2007) Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer. AJR Am J Roentgenol 188:257–267

    Article  PubMed  Google Scholar 

  20. Maas M, Rutten IJ, Nelemans PJ et al (2011) What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A metaanalysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 38:1560–1571

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gearhart SL, Frassica D, Rosen R et al (2005) Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer. Ann Surg Oncol 13:397–404

    Article  Google Scholar 

  22. Moore HG, Akhurst T, Larson SM et al (2003) A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. J Am Coll Surg 197:22–28

    Article  PubMed  Google Scholar 

  23. Even-Sapir E, Parag Y, Lerman H et al (2004) Detection of recurrence in patients with rectal cancer: PET/CT after abdomino-perineal or anterior resection. Radiology 232:815–822

    Article  PubMed  Google Scholar 

  24. Peng NJ, Hu C, King TM et al (2013) Detection of resectable recurrences in colorectal cancer patients with 2-18Ffluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography. Cancer Biother Radiopharm 28:479–487

    Article  PubMed  PubMed Central  Google Scholar 

  25. Von Schulthess GK, Steinert HC, Hany TF (2006) Integrated PET/CT: current applications and future directions. Radiology 238:405–22

    Article  Google Scholar 

  26. Schaefer O, Langer M (2007) Detection of recurrent rectal cancer with CT, MRI and PET/CT. Eur Radiol 17:2044–2054

    Article  CAS  PubMed  Google Scholar 

  27. Van Cutsem E, Nordlinger B, Cervantes A et al (2010) Advanced colorectal cancer: ESMO clinical practice guidelines for treatment. Ann Oncol 21(Suppl 5):93–97

    Article  Google Scholar 

  28. Dicle O, Obuz F, Cakmakci H (1999) Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 72:1155–1159

    Article  CAS  PubMed  Google Scholar 

  29. Tan PL, Chan CL, Moore NR (2005) Radiological appearances in the pelvis following rectal cancer surgery. ClinRadiol 60:846–855

    CAS  Google Scholar 

  30. Messiou C, Chalmers AG, Boyle K et al (2008) Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 81:468–473

    Article  CAS  PubMed  Google Scholar 

  31. Dresen RC, Kusters M, Daniels-Gooszen AW et al (2010) Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 256:143–150

    Article  PubMed  Google Scholar 

  32. Fusco R, Sansone M, Petrillo M et al (2011) Dynamic contrast enhanced magnetic resonance imaging in rectal cancer, rectal cancer – a multidisciplinary approach to management. Santoro GA (Ed.), ISBN: 978-953-307-758-1, InTech, DOI: 10.5772/26269

    Google Scholar 

  33. Fusco R, Petrillo A, Petrillo M, Sansone M (2013) Use of Tracer Kinetic Models for Selection of Semi-Quantitative Features for DCE-MRI Data Classification. Appl Magn Reson 44:1311–1324

    Article  CAS  Google Scholar 

  34. Fusco R, Sansone M, Petrillo M et al (2014) Role of magnetic resonance imaging in locally advanced rectal cancer, colorectal cancer - surgery, diagnostics and treatment. Khan J (Ed.), ISBN: 978-953-51-1231-0, InTech, DOI: 10.5772/56831

    Google Scholar 

  35. Petrillo A, Fusco R, Granata V et al (2014) Dynamic contrast enhanced-MRI in locally advanced rectal cancer: Value of Time Intensity Curve Visual Inspection to assess neo-adjuvant therapy response. The Journal of Physiology and Health. Photon 110:255–267

    Google Scholar 

  36. Petrillo M, Fusco R, Catalano O et al (2014) Assessment of neo-adjuvant therapy response in locally advanced rectal cancer using MR volumetry based on dynamic contrast enhanced images and diffusion-weighted data sets: A preliminary report. The Journal of Physiology and Health. Photon 110:268–278

    Google Scholar 

  37. Lambregts DM, Cappendijk VC, Maas M et al (2011) Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 21:1250–1258

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kim DJ, Kim JH, Lim JS et al (2010) Restaging of rectal cancer with MR imaging after concurrent chemotherapy and radiation therapy. Radiographics 30:503–516

    Article  PubMed  Google Scholar 

  39. Barbaro B, Vitale R, Leccisotti L et al (2010) Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30:699–716

    Article  PubMed  Google Scholar 

  40. Arulampalam T, Costa D, Visvikis D et al (2001) The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 28:1758–1765

    Article  CAS  PubMed  Google Scholar 

  41. Imbriaco M, Akhurst T, Hilton S et al (2000) Whole-body FDG-PET in patients with recurrent colorectal carcinoma. A comparative study with CT. Clin Positron Imaging 3:107–114

    Article  PubMed  Google Scholar 

  42. Järv V, Blomqvist L, Holm T et al (2000) Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma. Acta Radiol 41:629–633

    Article  PubMed  Google Scholar 

  43. Ogunbiyi OA, Flanagan FL, Dehdashti F et al (1997) Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4:613–620

    Article  CAS  PubMed  Google Scholar 

  44. Keogan MT, Lowe VJ, Baker ME et al (1997) Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. Abdom Imaging 22:332–337

    Article  CAS  PubMed  Google Scholar 

  45. Schiepers C, Penninckx F, De Vadder N et al (1995) Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 21:517–22

    Article  CAS  PubMed  Google Scholar 

  46. Kyoto Y, Momose M, Kondo C et al (2010) Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentration. Ann Nucl Med 24:395–401

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonella Petrillo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Italia

About this chapter

Cite this chapter

Petrillo, A., Fusco, R., Catalano, O. (2016). Imaging Modalities. In: Romano, G.M. (eds) Multimodal Treatment of Recurrent Pelvic Colorectal Cancer. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5767-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-5767-8_3

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-5766-1

  • Online ISBN: 978-88-470-5767-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics